The role of test accuracy in predicting acceptance of genetic susceptibility testing for Alzheimer's disease

Genetic Testing

Volumn 8, Issue 2, 2004, Pages 120-126

  Bassett, Susan Spear ^a,d   Havstad, Suzanne L ^b   Chase, Gary A ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; DIAGNOSTIC ACCURACY; FEMALE; GENETIC RISK; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREDICTION; PROGENY; PROGNOSIS; REVIEW;

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; QUESTIONNAIRES;

EID: 4143139692     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2004.8.120     Document Type: Review

References (44)

1. ACMG/ASHG WORKING GROUP. (1995). Statement on use of apolipoprotein E testing for Alzheimer disease. J. Am. Med. Assn. 274, 1627-1629.
2. ARMSTRONG, K., STOPFER, J., CALZONE, K., FITZGERALD, G., COYNE, J., and WEBER, B. (2002). What does my doctor think? Preferences for knowing the doctor's opinion among women considering clinical testing for BRCA1/2 mutations. Genet. Test. 6, 115-118.
3. ARO, A.R., HAKONEN, A., HIETALA, M., LONNQVIST, J., NIEMELA, P., PELTONEN, L., and AULA, P. (1997). Acceptance of genetic testing in a general population: age, education and gender differences. Patient. Educ. Couns. 32, 41-49.
4. BACHMAN, D.L., WOLF, P.A., LINN, R., KNOEFEL, J.E., COBB, J., BELANGER, A., D'AGOSTINO, R.B., and WHILE, L.R. (1992). Prevalence of dementia and probable senile dementia of the Alzheimer's type in the Framingham Study. Neurology 42, 115-119.
5. BACHMAN, D.L., WOLF, P.A., LINN, R.T., KNOEFEL, J.E., COBB, J.L., BELANGER, A.J., WHITE, L.R., and D'AGOSTION, R.B. (1993). Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 43, 515-519.
6. BENNETT, C., CRAWFORD, F., OSBORNE, A., DIAZ, P., HOYNE, J., LOPEZ, R., ROQUES, P., DUARA, R., ROSSOR, M., and MULLAN, M. (1995). Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative. Am. J. Med. Genet. 60, 1-6.
7. BLACKER, D., BERTRAM, L., SAUNDERS, A.J., MOSCARILLO, T.J., ALBERT, M.S., WIENER, H., PERRY, R.T., COLLINS, J.S., HARRELL, L.E., GO, R.C., MAHONEY, A., BEATY, T., FALLIN, M.D., AVRAMOPOULOS, D., CHASE, G.A., FOLSTEIN, M.F., MCINNIS, M.G., BASSETT, S.S., DOHENY, K.J., PUGH, E.W., and TANZI, R.E. (2003). Results of a high-resolution genome screen of 437 Alzheimer's Disease families. Hum. Mol. Genet. 12, 23-32.
8. BOSOMPRA, K., FLYNN, B.S., ASHIKAGA, T., RAIRIKAR, C.J., WORDEN, J.K., and SOLOMON, L.J. (2000). Likelihood of undergoing genetic testing for cancer risk: a population-based study. Prev. Med. 30, 155-166.
9. BROOKMEYER, R., GRAY, S., and KAWAS, C. (1998). Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am. J. Publ. Health 88, 1337-1342.
10. CANADIAN STUDY OF HEALTH AND AGING. (1994). The Canadian Study of Health and Aging: risk factors for Alzheimer's disease in Canada. Neurology 44, 2073-2080.
11. CHASE, G.A., GELLER, G., HAVSTAD, S.L., HOLTZMAN, N.A., and BASSETT, S.S. (2002). Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. Genet. Med. 4, 297-303.
12. EVANS, D.A., FUNKENSTEIN, H.H., ALBERT, M.S., SCHERR, P.A., COOK, N.R., CHOWN, M.J., HEBERT, L.E., HENNEKENS, C.H., and TAYLOR, J.O. (1989). Prevalence of Alzheimer's disease in a community population of older persons. J. Am. Med. Assn. 262, 2551-2556.
13. FARRER, L.A., O'SULLIVAN, D.M., CUPPLES, L.A., GROWDON, J.H., and MYERS, R.H. (1989). Assessment of genetic risk for Alzheimer's disease among first-degree relatives. Ann. Neurol. 25, 485-493.
14. GEORGE-HYSLOP, P.H. (2000). Molecular genetics of Alzheimer's disease. Biol. Psychiatr. 47, 183-199.
15. GOATE, A.M., HAYNES, A.R., OWEN, M.J., FARRALL, M., JAMES, L.A., LAI, L.Y., MULLAN, M.J., ROQUES, P., ROSSOR, M.N., WILLIAMSON, R., and HARDY, J.A. (1989). Predisposing locus for Alzheimer's disease on chromosome 21. Lancet 1, 352-355.
16. HARTENBACH, E.M., BECKER, J.M., GROSEN, E.A., BAILEY, H.H., PETEREIT, D.G., LAXOVA, R., and SCHINK, J.C. (2002). Progress of a Comprehensive Familial Cancer Genetic Counseling Program in the Era of BRCA1 and BRCA2. Genet. Test. 6, 75-78.
17. HERBERT, L.E., SCHERR, P.A., BECKETT, L.A., ALBERT, M.S. et al. (1995). Age-specific incidence of Alzheimer's disease in a community population. J. Am. Med. Assn. 273, 1354-1359.
18. HUFF, F.J., AUERBACH, J., CHAKRAVARTI, A., and BOLLER, F. (1988). Risk of dementia in relatives of patients with Alzheimer's disease. Neurology 38, 786-790.
19. JOHNSON, C.G., LEVENKRON, J.C., SUCHMAN, A.L., and MANCHESTER, R. (1988). Does physician uncertainty affect patient satisfaction? J. Gen. Intern. Med. 3, 144-149.
20. KEHOE, P., WAVRANT-DEVRIEZE, F., CROOK, R., WU, W., HOLMANS, P., FENTON, I., SPURLOCK, G., NORTON, N., WILLIAMS, H., WILLIAMS, N., LOVESTONE, S., PEREZ-TUR, J., HUTTON, M., CHARTIER-HARLIN, M.C., SHEARS, S., ROEHL, K., BOOTH, J., VORST, W.V., RAMIC, D., WILLIAMS, J., GOATE, A., HARDY, J., and OWEN, M.J. (1999). A full genome scan for late onset Alzheimer's disease. Hum. Mol. Genet. 8, 237-245.
21. KOKMEN, E., BEARD, C.M., O'BRIEN, P.C., OFFORD, K.P., and KURLAND, L.T. (1993). Is the incidence of dementing illness changing? A 25-year time trend study in Rochester, Minnesota (1960-1984). Neurology 43, 1887-1892.
22. LAUTENSCHLAGER, N.T., CUPPLES, L.A., RAO, V.S., AUERBACH, S.A., BECKER, R., BURKE, J., CHUI, H., DUARA, R., FOLEY, E.J., GLATT, S.L., GREEN, R.C., JONES, R., KARLINSKY, H., KUKULL, W.A., KURZ, A., LARSON, E.B., MARTELLI, K., SADOVNICK, A.D., VOLICER, L., WARING, S.C., GROWDON, J.H., and FARRER, L.A. (1996). Risk of dementia among relatives of Alzheimer's disease patients in the MIRAGE study: What is in store for the oldest old? Neurology 46, 641-650.
23. LERMAN, C., DALY, M., MASNY, A., and BALSHEM, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. J. Clin. Oncol. 12, 843-850.
24. LERMAN, C., NAROD, S., SCHULMAN, K., HUGHES, C., GOMEZ-CAMINERO, A., BONNEY, G., GOLD, K., TROCK, B., MAIN, D., LYNCH, J., FULMORE, C., SNYDER, C., LEMON, S.J., CONWAY, T., TONIN, P., LENOIR, G., and LYNCH, H. (1996). BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. J. Am. Med. Assn. 275, 1885-1892.
25. LETENNEUR, L., COMMENGES, D., DARTIGUES, J.F., and BERBEGER-GATEAU, P. (1994). Incidence of dementia and Alzheimer's disease in elderly community residents of South-Western France. Int. J. Epidemiol. 23, 1256-1261.
26. LEVY-LAHAD, E., WASCO, W., POORKAJ, P., ROMANO, D.M., OSHIMA, J., PETTINGELL, W.H., YU, C.E., JONDRO, P.D., SCHMIDT, S.D., and WANG, K. (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus [see comments]. Science 269, 973-977.
27. LI, G., SILVERMAN, J.M., SMITH, C.J., ZACCARIO, M.L., SCHMEIDLER, J., MOHS, R.C., and DAVIS, K.L. (1995). Age at onset and familial risk in Alzheimer's disease. Am. J. Psychiatr. 152, 424-430.
28. MARTEAU, T.M., and CROYLE, R.T. (1998). The new genetics. Psychological responses to genetic testing. Br. Med. J. 316, 693-696.
29. MARTEAU, T.M., DUNDAS, R., and AXWORTHY, D. (1997). Long-term cognitive and emotional impact of genetic testing for carriers of cystic fibrosis: the effects of test result and gender. Health Psychol. 16, 51-62.
30. MAYEUX, R., SAUNDERS, A.M., SHEA, S., MIRRA, S., EVANS, D., ROSES, A.D., HYMAN, B.T., CRAIN, B., TANG, M.X., and PHELPS, C.H. (1998). Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl. J. Med. 338, 506-511.
31. PERICAK-VANCE, M.A., BASS, M.P., YAMAOKA, L.H., GASKELL, P.C., SCOTT, W.K., TERWEDOW, H.A., MENOLD, M.M., CONNEALLY, P.M., SMALL, G.W., VANCE, J.M., SAUNDERS, A.M., ROSES, A.D., and HAINES, J.L. (1997), Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12 [see comments]. J. Am. Med. Assn. 278, 1237-1241.
32. QUAID, K.A., and MORRIS, M. (1993). Reluctance to undergo predictive testing: the case of Huntington disease. Am. J. Med. Genet. 45, 41-45.
33. ROBERTS, J.S. (2000). Anticipating response to predictive genetic testing for Alzheimer's disease: a survey of first-degree relatives. Gerontologist 40, 43-52.
34. ROCCA, W.A. (1994). Frequency, distribution, and risk factors for Alzheimer's disease. Nursing Clin. N. Am. 29, 101-111.
35. ROSES, A.D., and SAUNDERS, A.M. (1994). APOE is a major susceptibility gene for Alzheimer's disease. Curr. Opin. Biotechnol. 5, 663-667.
36. SAUNDERS, A.M., STRITTMATTER, W.J., SCHMECHEL, D., GEORGE-HYSLOP, P.H., PERICAK-VANCE, M.A., JOO, S.H., ROSI, B.L., GUSELLA, J.F., CRAPPER-MACLACHLAN, D.R., and ALBERTS, M.J. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease, Neurology 43, 1467-1472.
37. SCHELLENBERG, G.D., BIRD, T.D., WIJSMAN, E.M., ORR, H.T., ANDERSON, L., NEMENS, E., WHITE, J.A., BONNYCASTLE, L., WEBER, J.L., and ALONSO, M.E. (1992), Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671.
38. SELKOE, D.J. (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766,
39. SESHADRI, S., DRACHMAN, D.A., and LIPPA, C.F. (1995). Apolipoprotein E e4 allele and the lifetime risk of Alzheimer's disease: what physicians know, and what they should know. Arch. Neurol. 52, 1074-1079.
40. SLOOTER, A.J., BRETELER, M.B., OTT, A., VAN BROECKHOVEN, C., and VAN DUIJN, C.M. (1996). APOE genotyping in differential diagnosis of Alzheimer's disease. Lancet 348, 334.
41. STRITTMATTER, W.J., SAUNDERS, A.M., SCHMECHEL, D., PERICAK-VANCE, M., ENGHILD, J., SALVESEN, G.S., and ROSES, A.D. (1993). Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
42. STRUEWING, J.P., LERMAN, C., KASE, R.G., GIAMBARRESI, T.R., and TUCKER, M.A. (1995). Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol. Biomarkers Prev. 4, 169-173.
43. THILMANN, P., ERNST, C., CZECH, C., KAUMEIER, S., BEYREUTHER, K., and FORSTL, H. (1996). Low apolipoprotein E4 allelic frequency in Alzheimer's disease and functional psychiatric disorders. Dementia 7, 118-119.
44. WROE, A., SALKOVSKIS, P., and RIMES, K. (1998). The prospect of predictive testing for personal risk: attitudes and decision making. Behav. Res. Ther. 36, 599-619.